Relmada Therapeutics
RLMD
$0.48
Share price
10.78%
Change (1 day)
-93.61%
Change (1 year)
Categories
Relmada Therapeutics (RLMD) - Total assets
Total assets on the balance sheet as of September 2024 : A$89.06 Million
According to Relmada Therapeutics's latest financial reports the company's total assets are A$89.06 Million. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Relmada Therapeutics - Total assets on balance sheet (from 2012 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | A$0.14 B | -36.28% |
| 2022-12-31 | A$0.22 B | -27.06% |
| 2021-12-31 | A$0.30 B | 100.42% |
| 2020-12-31 | A$0.15 B | |
| 2019-06-30 | A$14.55 M | 253.48% |
| 2018-06-30 | A$4.11 M | 11.54% |
| 2017-06-30 | A$3.69 M | -73.08% |
| 2016-06-30 | A$13.71 M | -56.86% |
| 2015-06-30 | A$31.79 M | 16.2% |
| 2014-06-30 | A$27.35 M | |
| 2013-08-31 | A$0.02 M | 25.9% |
| 2012-08-31 | A$0.01 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 | A$3.45 B | 3,781.92% | 🇮🇱 Israel |
 | A$2.24 B | 2,415.36% | 🇺🇸 USA |